Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7
MUCOSAL IMMUNOLOGY
Authors: Hashimoto-Hill, S.; Friesen, L.; Kim, M.; Kim, C. H.
Abstract
The intestinal environment harbors a large number of activated T cells, which are potentially inflammatory. To prevent inflammatory responses, intestinal T cells are controlled by various tolerogenic mechanisms, including T-cell apoptosis. We investigated the expression mechanism and function of the purinergic receptor P2X7 in contraction of intestinal CD4(+) effector T cells. We found that P2X7 upregulation on CD4(+) effector T cells is induced by retinoic acid through retinoic acid receptor alpha binding to an intragenic enhancer region of the P2rx7 gene. P2X7 is highly expressed by most intestinal alpha beta and gamma delta T cells, including T-helper type 1 (Th1) and Th17 cells. The intestinal effector T cells are effectively deleted by P2X7 activation-dependent apoptosis. Moreover, P2X7 activation suppressed T-cell-induced colitis in Rag1(-/-) mice. The data from vitamin A-deficient and P2rx7(-/-) mice indicate that the retinoic acid-P2X7 pathway is important in preventing aberrant buildup of activated T cells. We conclude that retinoic acid controls intestinal effector T-cell populations by inducing P2X7 expression. These findings have important ramifications in preventing inflammatory diseases in the intestine.
Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer
ELIFE
Authors: Burfeind, Kevin G.; Zhu, Xinxia; Norgard, Mason A.; Levasseur, Peter R.; Huisman, Christian; Buenafe, Abigail C.; Olson, Brennan; Michaelis, Katherine A.; Torres, Eileen Rs; Jeng, Sophia; McWeeney, Shannon; Raber, Jacob; Marks, Daniel L.
Abstract
Weight loss and anorexia are common symptoms in cancer patients that occur prior to initiation of cancer therapy. Inflammation in the brain is a driver of these symptoms, yet cellular sources of neuroinflammation during malignancy are unknown. In a mouse model of pancreatic ductal adenocarcinoma (PDAC), we observed early and robust myeloid cell infiltration into the brain. Infiltrating immune cells were predominately neutrophils, which accumulated at a unique central nervous system entry portal called the velum interpositum, where they expressed CCR2. Pharmacologic CCR2 blockade and genetic deletion of Ccr2 both resulted in significantly decreased brain-infiltrating myeloid cells as well as attenuated cachexia during PDAC. Lastly, intracerebroventricular blockade of the purinergic receptor P2RX7 during PDAC abolished immune cell recruitment to the brain and attenuated anorexia. Our data demonstrate a novel function for the CCR2/CCL2 axis in recruiting neutrophils to the brain, which drives anorexia and muscle catabolism.